YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Short Interest Update

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) was the recipient of a significant decrease in short interest in August. As of August 14th, there was short interest totaling 67,120 shares, a decrease of 56.7% from the July 30th total of 154,895 shares. Approximately 0.9% of the company’s stock are sold short. Based on an average daily trading volume, of 111,339 shares, the short-interest ratio is currently 0.6 days.

YieldMax MRNA Option Income Strategy ETF Price Performance

Shares of MRNY traded down $0.77 on Friday, hitting $32.62. 194,622 shares of the stock traded hands, compared to its average volume of 238,141. YieldMax MRNA Option Income Strategy ETF has a one year low of $13.60 and a one year high of $42.39. The business has a 50 day simple moving average of $19.81 and a 200 day simple moving average of $18.44.

About YieldMax MRNA Option Income Strategy ETF

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.